Phoenix Financial Ltd. Invests $203,000 in Cardinal Health, Inc. $CAH

Phoenix Financial Ltd. purchased a new position in Cardinal Health, Inc. (NYSE:CAH) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,205 shares of the company’s stock, valued at approximately $203,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Greykasell Wealth Strategies Inc. bought a new position in shares of Cardinal Health during the first quarter worth $26,000. Jones Financial Companies Lllp boosted its holdings in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the last quarter. GW&K Investment Management LLC boosted its holdings in shares of Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after purchasing an additional 144 shares during the last quarter. Harbor Asset Planning Inc. bought a new position in shares of Cardinal Health during the 2nd quarter valued at about $49,000. Finally, Zions Bancorporation National Association UT bought a new position in shares of Cardinal Health during the 1st quarter valued at about $52,000. 87.17% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Cardinal Health news, insider Ola M. Snow sold 28,151 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the sale, the insider owned 15,431 shares of the company’s stock, valued at $2,298,293.14. This trade represents a 64.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Michelle D. Greene sold 13,500 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $2,009,070.00. Following the sale, the insider directly owned 14,976 shares of the company’s stock, valued at $2,228,728.32. This represents a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock valued at $40,489,525 over the last quarter. Corporate insiders own 0.12% of the company’s stock.

Cardinal Health Stock Down 0.2%

Shares of CAH opened at $159.21 on Friday. The company has a market cap of $37.83 billion, a PE ratio of 24.68, a P/E/G ratio of 1.35 and a beta of 0.71. The business has a fifty day moving average of $152.51 and a 200 day moving average of $152.43. Cardinal Health, Inc. has a 52-week low of $106.98 and a 52-week high of $168.44.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. The company had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.Cardinal Health’s revenue was up .5% on a year-over-year basis. During the same period last year, the company earned $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. The ex-dividend date was Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is 31.63%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Robert W. Baird increased their price target on Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research note on Wednesday, August 13th. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 2nd. UBS Group reiterated a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Finally, Jefferies Financial Group set a $150.00 price objective on shares of Cardinal Health in a research report on Tuesday, August 12th. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $166.00.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.